看好医药。受诺和诺德_老虎社区_美港股上老虎

岿然不动的稳
2023-10-17

看好医药。受诺和诺德司美格鲁肽FLOW研究中期分析结果的消息影响，减肥药概念股持续活跃。短期交易减肥药主题超预期，中长期创新&国际化龙头企业药企未来可期。 $诺和诺德(NVO)$

# 减肥药双雄续刷历史新高，你出手了吗？

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":231572853198864,"tweetId":"231572853198864","gmtCreate":1697544851731,"gmtModify":1697544853280,"author":{"id":9000000000000286,"authorId":9000000000000286,"authorIdStr":"9000000000000286","name":"岿然不动的稳","avatar":"https://static.tigerbbs.com/486f271ec3baea83584935933913eb15","vip":8,"userType":8,"introduction":"运营账号","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":22,"starInvestorFlag":false},"themes":[{"themeId":"860d98ac43fa4a79b0f05f1e6b69beca","categoryId":"d316d8bd4a714fab9ea15fd7157c45e7","name":"减肥药双雄续刷历史新高，你出手了吗？","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":860d98ac43fa4a79b0f05f1e6b69beca}&rnconfig={\"headerBarHidden\": true}","description":"据悉，诺和诺德和礼来的新型减肥药在美国的风靡，已经开始对传统的食品饮料行业造成冲击，美国两大饮料巨头可口可乐和百事分别大跌4.83%和5.22%，市值在一个交易日内蒸发115亿美元和121.3亿美元。此前，美国商超巨头沃尔玛一名高管发出警告，称那些正在服用Ozempic、Wegovy等GLP-1受体激动剂的消费者的购物需求有所降低，这类新型减肥药可能引起美国食品业发生重大变革。对此，你怎么看？","image":"https://static.tigerbbs.com/17168dd72ddb08f6868ca9c835c18a92"}],"images":[],"coverImages":[],"html":"<html><head></head><body><p>看好医药。受诺和诺德司美格鲁肽FLOW研究中期分析结果的消息影响，减肥药概念股持续活跃。短期交易减肥药主题超预期，中长期创新&amp;国际化龙头企业药企未来可期。 <a data-mention-id=\"NVO\" class=\"teditor-mention\" data-mention-name=\"诺和诺德\" href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a> </p></body></html>","htmlText":"<html><head></head><body><p>看好医药。受诺和诺德司美格鲁肽FLOW研究中期分析结果的消息影响，减肥药概念股持续活跃。短期交易减肥药主题超预期，中长期创新&amp;国际化龙头企业药企未来可期。 <a data-mention-id=\"NVO\" class=\"teditor-mention\" data-mention-name=\"诺和诺德\" href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a> </p></body></html>","text":"看好医药。受诺和诺德司美格鲁肽FLOW研究中期分析结果的消息影响，减肥药概念股持续活跃。短期交易减肥药主题超预期，中长期创新&国际化龙头企业药企未来可期。 $诺和诺德(NVO)$","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/231572853198864","repostId":0,"isVote":1,"tweetType":1,"viewCount":575,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["NVO"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":159,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}